Who Paid My Doc
Gelfoam
Device Hemostat
PDI 10300090315082
General payments
$32,918
Research payments
$0
Through program year 2025, $32,918 in general payments and $0 in research payments were reported against Gelfoam (Hemostat).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,508 | 66 |
| 2024 | General | $4,518 | 209 |
| 2023 | General | $17,473 | 203 |
| 2022 | General | $115 | 6 |
| 2021 | General | $9,304 | 66 |
Breakdown
The top 5 of 59 recipients; each share is of general payments naming this product in 2025.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
550 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.